Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

The Lancet

Volumn 343, Issue 8904, 1994, Pages 1006-1008

  Sullivan, P ^a   Jaffar, Z ^a   Page, C ^a   Costello, J ^a   Bekir, S ^b   Jeffery, P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028344025     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90127-9     Document Type: Article

References (19)

1. Cellular events in the bronchi in mild asthma and after bronchial provocation
2. Mucosal inflammation in asthma
3. Guidelines on the Management of Asthma
4. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
5. Acute adverse reactions to prednisone in relation to dosage
6. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline
7. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs
8. Withdrawing chronic theophylline treatment increases airway lymphocytes in asthma
9. The effect of theophylline and emprofylline on allergen induced bronchoconstriction
10. Bronchoalveolar lavage eosinophilia during allergen induced late asthmatic reactions
11. Theophylline—an immunomodulatory role in asthma?
12. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma
13. Eosinophil and neutrophil activity in asthma in a one-year double blind trial with theophylline and two doses of inhaled budesonide
14. The potential roles of leukotrienes in bronchial asthma
15. Eicosanoids and platelet activating factor in allergic respiratory diseases
16. Regional and time dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig
17. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid
18. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
19. Overview of effects of theophylline